Ropes & Gray advised Sanofi on the deal. Sanofi announced a strategic equity investment in Torino, Italy-based Resalis Therapeutics (Resalis Therapeutics). The company plans to use...
You must be a Standard 1 Year member to access this content.
Vinge advised Vicore Pharma Holding AB on the deal, and Ropes & Gray advised Sanofi. Vicore Pharma Holding AB (publ) secured a directed share issue, whereby...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Sanofi in the transaction, and Wilson Sonsini Goodrich & Rosati represented Ventyx Biosciences, Inc. Sanofi announced a $27 million strategic investment in...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Sanofi on the transaction, and Goodwin Procter advised Vigil Neuroscience. Sanofi (Nasdaq: SNY) has made a $40 million strategic investment in Vigil...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Ionis Pharmaceuticals in the deal. Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) has entered into a license agreement with Otsuka Pharmaceutical Co., Ltd. (Otsuka)...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Nona Biosciences on the deal. Nona Biosciences announced it has entered into a license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for preclinical monoclonal...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Xeris Biopharma Holdings on the transaction. Xeris Biopharma Holdings, Inc. (Nasdaq:XERS) (Xeris), a biopharmaceutical company, announced that it has entered into an exclusive worldwide...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised G1 Therapeutics, Inc. on the transaction. G1 Therapeutics (Nasdaq: GTHX) announced it has entered into a global license agreement, excluding the Asia Pacific region, with...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Teva Pharmaceuticals International GmbH in the deal. Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Blackstone Life Sciences in the transaction. Blackstone Life Sciences (NYSE:BX) (“Blackstone”) announced a collaboration with Moderna, Inc. (NASDAQ: MRNA, “Moderna”) through a development and...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Solid Biosciences on the transaction. Solid Biosciences (Nasdaq: SLDB), a biotechnology company specializing in genetic medicines for neuromuscular and cardiac diseases, announced...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised AbbVie on the deal. AbbVie (NYSE: ABBV), and Umoja Biopharma (Umoja) Umoja Biopharma announced two exclusive option and license agreements to develop multiple in-situ...
You must be a Standard 1 Year member to access this content.
